Prosecution Insights
Last updated: May 29, 2026
Application No. 18/018,672

SOLID FOOD AND SOLID MILK

Final Rejection §102§112§DOUBLEPATENT
Filed
Jan 30, 2023
Priority
Jul 31, 2020 — JP 2020-131180 +1 more
Examiner
DUBOIS, PHILIP A
Art Unit
1791
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Meiji Co. Ltd.
OA Round
2 (Final)
25%
Grant Probability
At Risk
3-4
OA Rounds
1y 4m
Est. Remaining
50%
With Interview

Examiner Intelligence

Grants only 25% of cases
25%
Career Allowance Rate
130 granted / 519 resolved
-40.0% vs TC avg
Strong +25% interview lift
Without
With
+25.4%
Interview Lift
resolved cases with interview
Typical timeline
4y 8m
Avg Prosecution
34 currently pending
Career history
598
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
85.5%
+45.5% vs TC avg
§102
3.4%
-36.6% vs TC avg
§112
4.6%
-35.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 519 resolved cases

Office Action

§102 §112 §DOUBLEPATENT
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group 2, claims 3-4 in the reply filed on 6/5/2025 is acknowledged. Claims 1-2 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 6/5/2025Cla. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 3-4 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 3 is confusing. Claim 3 recites crystallization ratios based on a surface value and an “inner part” value. However, it is unclear where the “inner part” of the solid milk is located and to be measured. Moreover, the claim appears to require an increase ratio β based on the overall amount of α and β lactose crystals relative to the surface and inner part. The claim also appears to require an increase ratio α based on the overall amount of α and β lactose crystals relative the surface an inner part. However, the claim also recites that increase ratio β take into account the “sum of (α + β) of an increase α” to arrive at an increase β (% by weight) in crystallization rate is 0.15 or more. It is unclear how both increasing ratios relate to determining the increase in β. It is suggested that the claim be rewritten to clearly define each ratio. Claim 3 is also rejected for reciting a peel and shear stress on a flat face. It is unclear what the flat face references. Claim 4 is rejected as it depends on claim 3 as a base claim and includes all the limitations of the base claim. Claim Rejections - 35 USC § 102/103 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 3 and 4 are rejected under 35 U.S.C. 102(a)(1) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over WO2007/077970 (SHIBATA). PNG media_image1.png 732 562 media_image1.png Greyscale SHIBATA teaches a solid milk (pg. 5, lines 10-15). The sold milk is produced by compressing powdered milk (i.e., milk naturally contains lactose with α and β isomers) with a compression speed of 0.1 mm/s – 100 mm/s and then treating the milk product to a humidification process having 60%RH-100%RH and a temperature of 30-I500C. (pg. 18, lines 5-32). The present specification also teaches forming a solid milk product with similar process requirements. In particular, the present invention utilizes a compression speed of 1 mm/s and humidifies the product at a temperature of 101oC and with an RH of 100% or less (see pg. 53, last paragraph and compression speed and temperature of Example 1 beginning on page 75 of specification). Given SHIBATA also teaches forming a solid milk product with the same product (i.e., milk powder) and process requirements of the present application, SHIBATA inherently teaches the claimed crystallization and stress values. Moreover, it is noted that the manner in which the solid milk is obtained a process recitation. "[E]ven though product-by-process claims are limited by and defined by the process, determination of patentability is based on the product itself. The patentability of a product does not depend on its method of production. If the product in the product-by-process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process." In re Thorpe, 777 F.2d 695, 698, 227 USPQ 964, 966 (Fed. Cir. 1985) (citations omitted) (Claim was directed to a novolac color developer. The process of making the developer was allowed. The difference between the inventive process and the prior art was the addition of metal oxide and carboxylic acid as separate ingredients instead of adding the more expensive pre-reacted metal carboxylate. The product-by-process claim was rejected because the end product, in both the prior art and the allowed process, ends up containing metal carboxylate. The fact that the metal carboxylate is not directly added, but is instead produced in-situ does not change the end product.). In the alternative, any slight differences in the composition as a result of the recited process steps would have been obvious to one of ordinary skill in the art and well within the ordinary level of skill to have produced. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 3-4 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 3-4 of copending Application No. 18/018,680 (680 Application). Although the claims at issue are not identical, they are not patentably distinct from each other because both applications are directed compression molded, solid food/milk products, with α and β lactose crystallization. The 680 application does not characterize the crystallization α and β lactose crystallization rates in terms of a ratio or recite a stress value. However, the 680 claims do require α and β lactose crystallization amounts at the surface and inner part of the product. It is considered the product would have the same stress value given both are directed to compressed milk powders with α and β lactose crystallization. The separate calculation of a ratio for α and β lactose crystals relative to the surface and inner part does not result in a patentable difference given both claims require lactose α and β crystallization. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Claims 3-4 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-4 of copending Application No. 18/018,673 (673 Application). Although the claims at issue are not identical, they are not patentably distinct from each other because both applications are directed compression molded, solid food/milk products, wherein crystallization rates differ at the surface of the product relative to the inner part of the product. Both applications use similar material (i.e., milk powder) and process requirements (i.e., compression molding of a milk product). While the 673 claims do not require that the crystallization be based on lactose, the product is a compressed milk product and milk naturally contains lactose. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to PHILIP A DUBOIS whose telephone number is (571)272-6107. The examiner can normally be reached M-F, 9:30-6:00p. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Nikki Dees can be reached on 571-270-3435. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PHILIP A DUBOIS/ Examiner, Art Unit 1791 /Nikki H. Dees/Supervisory Patent Examiner, Art Unit 1791
Read full office action

Prosecution Timeline

Jan 30, 2023
Application Filed
Oct 14, 2025
Non-Final Rejection mailed — §102, §112, §DOUBLEPATENT
Jan 14, 2026
Response Filed
May 26, 2026
Final Rejection mailed — §102, §112, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12628840
GROUP OF MICROORGANISMS COMPOSED BY LACTOBACILLUS SP STRAIN K03D08, BACILLUS SP STRAIN K03B01 AND KAZACHSTANIA SP STRAIN K03K02G AND ITS COMPOSITIONS; A PROCESS FOR OBTAINING CASEIN-FREE DAIRY DERIVATIVE CONTAINING SHORT-CHAIN FATTY ACIDS AND HYDROXYLATED SHORT-CHAIN FATTY ACIDS GENERATED BY THE METABOLISM OF THE GROUP OF MICROORGANISMS
3y 8m to grant Granted May 19, 2026
Patent 12618028
FERMENTED AND ESTERIFIED MOLASSES
3y 1m to grant Granted May 05, 2026
Patent 12599154
BEVERAGE
8y 12m to grant Granted Apr 14, 2026
Patent 12600930
Process for Aging Distilled Spirits
4y 10m to grant Granted Apr 14, 2026
Patent 12543755
COMPOSITION COMPRISING AN OIL PHASE
7y 10m to grant Granted Feb 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
25%
Grant Probability
50%
With Interview (+25.4%)
4y 8m (~1y 4m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 519 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month